
Analgesics in New Zealand
Description
Analgesics in New Zealand
Analgesics is set to see slow retail current value growth in New Zealand in 2024. During the period 2020-2021, the government’s response to the COVID-19 pandemic included movement restrictions and reduced levels of social interaction, which meant that incidences of seasonal cold and flu reduced year-over-year, which should have had a negative impact on sales of analgesics. Nevertheless, demand was instead driven by demand to relieve the symptoms of COVID-19. With reduced exposure to cold and flu...
Euromonitor International's Analgesics in New Zealand report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
25 Pages
- Analgesics in New Zealand
- Euromonitor International
- September 2024
- List Of Contents And Tables
- ANALGESICS IN NEW ZEALAND
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Cold and flu incidence rates up on 2023, driving growth in demand for analgesics
- Supermarkets and pharmacies remain the dominant distribution channels
- Inflationary pressures drive unit price growth, cost of living pressures drive growth for private label
- PROSPECTS AND OPPORTUNITIES
- Inflationary pressures expected to ease, unit price growth expected to slow
- Impact on analgesics of pseudoephedrine regulatory changes remains uncertain
- Strong brand awareness to drive continued dominance for the incumbent leaders, but the competition is increasing
- CATEGORY DATA
- Table 1 Sales of Analgesics by Category: Value 2019-2024
- Table 2 Sales of Analgesics by Category: % Value Growth 2019-2024
- Table 3 NBO Company Shares of Analgesics: % Value 2020-2024
- Table 4 LBN Brand Shares of Analgesics: % Value 2021-2024
- Table 5 Forecast Sales of Analgesics by Category: Value 2024-2029
- Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
- CONSUMER HEALTH IN NEW ZEALAND
- EXECUTIVE SUMMARY
- Consumer health in 2024: The big picture
- 2024 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
- MARKET INDICATORS
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
- Table 8 Life Expectancy at Birth 2019-2024
- MARKET DATA
- Table 9 Sales of Consumer Health by Category: Value 2019-2024
- Table 10 Sales of Consumer Health by Category: % Value Growth 2019-2024
- Table 11 NBO Company Shares of Consumer Health: % Value 2020-2024
- Table 12 LBN Brand Shares of Consumer Health: % Value 2021-2024
- Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
- Table 14 Distribution of Consumer Health by Format: % Value 2019-2024
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2024
- Table 16 Forecast Sales of Consumer Health by Category: Value 2024-2029
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
- APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 1 Research Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.